Department of Psychiatry, Amsterdam Neuroscience, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Amsterdam Brain and Cognition, Amsterdam, the Netherlands.
Mov Disord. 2021 Feb;36(2):317-326. doi: 10.1002/mds.28390. Epub 2020 Dec 16.
Apathy, the loss of motivation, is a common problem in Parkinson's disease (PD) and often observed following deep brain stimulation (DBS) of the subthalamic nucleus (STN). The aim of this meta-analysis was to determine the occurrence of apathy following STN DBS in literature. Relevant articles were searched in PubMed/Medline, SCOPUS, EMBASE, and Web of Sciences electronic databases. Studies were included if they reported apathy scores pre- and post-DBS or the cross-sectional difference between PD patients receiving STN DBS and patients receiving medication only. Thirty-three articles were included in the meta-analyses from 6,658 screened articles by two authors independently. A total of 1,286 patients were included with a mean age (±standard deviation [SD]) of 58.4 ± 8.5 years and a disease duration of 11.0 ± 5.8 years. The apathy score measured by means of the Apathy Evaluation Scale (AES), Starkstein Apathy Scale (SAS), and the Lille Apathy Rating Scale (LARS) was significantly higher after DBS than pre-operatively (g = 0.34, 95% confidence interval [CI] = 0.19-0.48, P < 0.001). An equal, significant difference in severity of apathy was found between STN DBS and medication only (g = 0.36, 95% CI = 0.03-0.65; P = 0.004). Statistical heterogeneity was moderately high, but the effects stood strong after multiple analyses and were independent of tapering off dopaminergic medication. The findings of this meta-analysis indicate that apathy is increased after STN DBS compared to the pre-operative state and to medication only (systematic review registration number: PROSPERO CRD42019133932). © 2020 Universiteit van Amsterdam. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
淡漠,即动机缺失,是帕金森病(PD)的常见问题,且常发生于丘脑底核(STN)深部脑刺激(DBS)之后。本荟萃分析旨在确定文献中 STN-DBS 后淡漠的发生情况。通过两位作者独立检索 PubMed/Medline、SCOPUS、EMBASE 和 Web of Sciences 电子数据库,搜索相关文章。如果文章报告了 DBS 前后的淡漠评分,或者 STN-DBS 治疗的 PD 患者与仅接受药物治疗的患者之间的横断面差异,则纳入研究。两位作者独立从 6658 篇筛选文章中纳入 33 篇进行荟萃分析。共有 1286 名患者纳入分析,平均年龄(±标准差[SD])为 58.4±8.5 岁,疾病病程为 11.0±5.8 年。采用淡漠评估量表(AES)、Starkstein 淡漠量表(SAS)和 Lille 淡漠评定量表(LARS)测量的淡漠评分,DBS 后显著高于术前(g=0.34,95%置信区间[CI]:0.19-0.48,P<0.001)。STN-DBS 和仅药物治疗之间的淡漠严重程度也存在显著差异(g=0.36,95%CI:0.03-0.65;P=0.004)。统计异质性中等偏高,但在多次分析后,效果仍然显著,且独立于多巴胺能药物的逐渐减少。这项荟萃分析的结果表明,与术前状态和仅药物治疗相比,STN-DBS 后淡漠程度增加(系统评价注册编号:PROSPERO CRD42019133932)。© 2020 阿姆斯特丹大学。运动障碍协会代表国际帕金森病与运动障碍协会在 Wiley Periodicals LLC 旗下出版《移动障碍》。